OACC

Oaktree Acquisition Iii Life Sciences
$10.68
$0.00 (0%)Oct 28, 2026
4.3NeutralMoatMint rating

MoatMint rates Oaktree Acquisition Iii Life Sciences (OACC) 4.3 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 3.4 out of 10.

Return+6.8%5YRange $9.96 - $10.93
$11.0$10.6$10.2$9.8Oct 24Oct 25Oct 26

Key metrics

The numbers that frame OACC today
Market cap
$262.54M
P/E (TTM)
36.8
ROIC
3.4%
Div yield
0%
52wk Low
$10.50
52wk High
$10.93

OACC stock rating

How OACC scores on quality, value, growth, momentum and financial health
4.3out of 10
Neutral overallFair business, full price
Quality3.4
Growth3.7
Momentum5.7
Value4.9
Financial Health6.4

Growth

Revenue and earnings trend for OACC
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about OACC
Is Oaktree Acquisition Iii Life Sciences a good buy?
Hold. Oaktree Acquisition Iii Life Sciences has weak quality and mixed momentum. The setup is mixed. Growth looks weak. That could put pressure on the long-term business case. We think Oaktree Acquisition Iii Life Sciences is selling at a fair price.
What is the market capitalization of OACC?
Oaktree Acquisition Iii Life Sciences's market capitalization is $262.54M.
What is the P/E (TTM) ratio for OACC stock?
Oaktree Acquisition Iii Life Sciences's P/E (TTM) ratio is 36.8, based on trailing earnings.
What is the 52-week high for OACC stock?
The 52-week high for Oaktree Acquisition Iii Life Sciences is $10.93. The current close of $10.68 is 2.3% below that high.
What is the 52-week low for OACC stock?
The 52-week low for Oaktree Acquisition Iii Life Sciences is $10.50. The current close of $10.68 is 1.7% above that low.
Does OACC stock pay dividends?
Oaktree Acquisition Iii Life Sciences does not currently show a dividend per share in the company data.